2003
DOI: 10.1590/s1415-52732003000300008
|View full text |Cite
|
Sign up to set email alerts
|

Efeitos do flavonóide quercetina e dos corantes bixina e norbixina sobre parâmetros sanguíneos de coelhos

Abstract: Efeitos do flavonóide quercetina e dos corantes bixina e norbixina sobre parâmetros sanguíneos de coelhos Effects of the flavonoid quercetin and the natural dyes bixin and norbixin on blood parameters of rabbits R E S U M OAvaliou-se a ação terapêutica da quercetina, bixina e norbixina, na dose diária de 0,01mol/kg, em coelhos hiperlipidêmicos induzidos por colesterol a 0,5% e ácido cólico a 0,1%, durante o período de vinte e oito dias, após o qual foram dosados colesterol, colesterol-HDL, triacilgliceróis, u… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0
2

Year Published

2009
2009
2017
2017

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(6 citation statements)
references
References 7 publications
(3 reference statements)
0
4
0
2
Order By: Relevance
“…Studies suggest low toxicity of some flavonoids present in T. majus leaves as quercetin (isoquercitrin aglycone) (NTP, 1992;Lima et al, 2003;Hard et al, 2007;Harwood et al, 2007), and the enzymatic produced isoquercitrin (EMIQ) (Hasamura et al, 2004;Tamura et al, 2010). However, the medicinal plants represent a complex mix of chemical components with biological activities that can cause adverse effects and interact with other medications when used concomitantly (Holstege et al, 2005;Venkataramanan et al, 2006;Jordan et al, 2010).…”
Section: Discussionmentioning
confidence: 99%
“…Studies suggest low toxicity of some flavonoids present in T. majus leaves as quercetin (isoquercitrin aglycone) (NTP, 1992;Lima et al, 2003;Hard et al, 2007;Harwood et al, 2007), and the enzymatic produced isoquercitrin (EMIQ) (Hasamura et al, 2004;Tamura et al, 2010). However, the medicinal plants represent a complex mix of chemical components with biological activities that can cause adverse effects and interact with other medications when used concomitantly (Holstege et al, 2005;Venkataramanan et al, 2006;Jordan et al, 2010).…”
Section: Discussionmentioning
confidence: 99%
“…A significant number of chemical properties and pharmacological effects have been attributed to quercetin in animal models, such as reduction of serum cholesterol levels 2 and anti-inflammatory action in lung injury. Rat models of various liver disorders have shown a hepatoprotective role of quercetin, which has been associated with increased survival in cirrhosis 3 and protection against induced liver damage 4,5 .…”
Section: Introductionmentioning
confidence: 99%
“…In our laboratory, we have been inducing hypercholesterolemia in rabbits by adding 1% of cholesterol to commercial chow in several studies with the purpose of investigating substances that can be further made viable as medications for the control of lipid metabolism, and also of developing tests of potential therapies and diagnosis between different experimental procedures [5][6][7][8][9][10][11][12] .…”
mentioning
confidence: 99%